About Aragen Life Sciences Limited
Data last updated:
Aragen Life Sciences Limited is a public limited company based in Hyderabad, Telangana, India. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 07 December 2000 and has been in existence for over 26 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U74999TG2000PLC035826. Its GSTIN is 36AABCG3208J1ZT (Telangana). The company holds 12 GST registrations, of which 6 are active.
The company has an authorised share capital of ₹250 Cr and a paid-up capital of ₹216.99 Cr. It was formerly known as Gvk Biosciences Private Limited. It is led by directors including Manmahesh Kantipudi (Managing Director) and Davinder Singh Brar.
Its last annual general meeting (AGM) was held on 27 June 2025, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Plot 28A Ida Nacharam, Hyderabad, Telangana, India – 500076.
As per the financials filed for FY 2025, the company reported a revenue of ₹1,870.29 Cr, a growth of 12% compared to the previous year. For the same year it recorded a net profit of ₹180.38 Cr (net margin 9.6%) and EBITDA of ₹478.48 Cr (EBITDA margin 25.6%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years and 14% over five years.
The company has about 3,859 employees on its provident fund (EPFO) records. Its group structure includes 2 subsidiaries.
The company is associated with 2 brands: GVK Davix Technologies and Aragen Life Sciences. As per MCA filings, the company has open charges of ₹583.8 Cr and satisfied charges of ₹768.38 Cr on record. Court records list 32 cases involving the company, including 11 filed by the company and 19 filed against it; 10 cases are pending. The company has 26 deals on record (21 secondary share transfers, 4 funding rounds, 1 acquisition), with disclosed funding of ₹1,040.25 Cr; the latest was in August 2025. Its 10 peer companies in the Pharma industry (API Manufacturers, Contract Research) are compared by revenue, 5 larger and 5 smaller; the largest is Iol Chemicals and Pharmaceuticals Limited with revenue of ₹2,101.62 Cr. The company has 46 MSME Form 1 returns on record between 2010 and 2024, listing 19,298 overdue payments to 864 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website gvkbio.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressPlot 28A Ida Nacharam, Hyderabad, Telangana, India – 500076
- IndustryPharma, Pharma Contract R&D
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Aragen Life Sciences Limited
The main business activities of Aragen Life Sciences are professional, scientific and technical and manufacturing. In detail, this covers scientific research and development and chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products. 2 activity segments are registered with the MCA.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development | Locked |
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Aragen Life Sciences Limited FY 2024 filings available
Aragen Life Sciences Limited reported revenue of ₹1,870.29 Cr (up 12% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Aragen Life Sciences Limited
Revenue has grown at a compounded annual rate (CAGR) of 14% over five years, including 12% growth in the latest year. EBITDA rose 6% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Aragen Life Sciences Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹478.48 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹180.38 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Aragen Life Sciences Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 25.6% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 9.6% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Aragen Life Sciences are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Aragen Life Sciences Limited
Aragen Life Sciences Limited is compared with the companies closest to it by revenue in the Pharma industry (API Manufacturers, Contract Research). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Iol Chemicals and Pharmaceuticals Limited Listed | ₹2,101.62 Cr (FY 2025) | •••• | •••• | -3.0% | •••• | Barnala, Punjab, India |
| Tianish Laboratories Private Limited | ₹2,059.53 Cr (FY 2024) | •••• | •••• | •••• | Hyderabad, Telangana, India | |
| Pfizer Healthcare India Private Limited | ₹1,981.45 Cr (FY 2025) | •••• | •••• | 4.0% | •••• | Chennai, Tamil Nadu, India |
| MSN Life Sciences Private Limited | ₹1,961.87 Cr (FY 2024) | •••• | •••• | 54.0% | •••• | Hyderabad, Telangana, India |
| Anthem Biosciences Limited | ₹1,930.28 Cr (FY 2025) | •••• | •••• | 30.0% | •••• | Bangalore, Karnataka, India |
| Aragen Life Sciences Limited this company | ₹1,870.29 Cr (FY 2025) | •••• | •••• | 12.0% | •••• | Hyderabad, Telangana, India |
| Hikal Limited Listed | ₹1,864.8 Cr (FY 2025) | •••• | •••• | 4.0% | •••• | Mumbai, Maharashtra, India |
| Aarti Pharmalabs Limited Listed | ₹1,857.5 Cr (FY 2024) | •••• | •••• | -5.0% | •••• | Vapi, Gujarat, India |
| Morepen Laboratories Limited Listed | ₹1,829.94 Cr (FY 2025) | •••• | •••• | 7.0% | •••• | Himachal Pradesh, India |
| Sai Life Sciences Limited | ₹1,731.35 Cr (FY 2025) | •••• | •••• | 16.0% | •••• | Hyderabad, Telangana, India |
| MSN Pharmachem Private Limited | ₹1,716.51 Cr (FY 2024) | •••• | •••• | 40.0% | •••• | Hyderabad, Telangana, India |
Peers are the five companies nearest above and the five nearest below Aragen Life Sciences by revenue in the Pharma industry (API Manufacturers, Contract Research), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Aragen Life Sciences Limited
Aragen Life Sciences Limited is audited by BSR & Co for the financial year 2024.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| BSR & Co | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors and KMP of Aragen Life Sciences Limited
Aragen Life Sciences Limited currently reports 8 directors and 1 key managerial person. 19 former directors have served the organization.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Davinder Singh Brar Also directs: Epl Limited, Mountain Trail Foods Private Limited, Madhubani Investments Private Limited and 5 more | Director | 26 Jul 2004 | 22 Years 2 Months | Current |
| Amit Varma Also directs: Cnext Health Solutions LLP, Encube Ethicals Private Limited, Nobel Hygiene Private Limited and 5 more | Director | 09 Jan 2025 | 1 Years 9 Months | Current |
| Ajay Srivastava | Director | 20 May 2021 | 5 Years 4 Months | Current |
| Anita Ramachandran | Director | 07 Nov 2022 | 3 Years 11 Months | Current |
| Rajat Sood Also directs: Girnar Insurance Brokers Private Limited, Girnar Finserv Private Limited, Peoplestrong Technologies Private Limited and 1 more | Director | 19 May 2021 | 5 Years 4 Months | Current |
| Manmahesh Kantipudi Also directs: Intox Private Limited, Aragen Biologics Private Limited, Zeroharm Sciences Private Limited and 2 more | Managing Director | 29 May 2018 | 8 Years 4 Months | Current |
Ownership and Shareholding of Aragen Life Sciences Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Aragen Life Sciences Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Apr 2025 | Citi Bank N.A. | ₹100 Cr | Open |
| 28 Mar 2024 | Others | ₹50 Cr | Open |
| 07 Dec 2021 | Citi Bank N.A. | ₹50 Cr | Open |
| 08 Nov 2021 | Others | ₹100 Cr | Open |
| 31 Mar 2020 | Others | ₹75 Cr | Open |
Total charge records: 27 View all charges
Deals & Funding of Aragen Life Sciences Limited
Aragen Life Sciences Limited has 26 deals on record (21 secondary share transfers, 4 funding rounds, 1 acquisition), with disclosed funding of ₹1,040.25 Cr; the latest was in August 2025.
Deals on record (5 of 26)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Aug 2025 | Funding round | ₹300 Cr | Investors: Avendus Capital, Sbi Life Insurance Company Limited |
| Dec 2006 | Secondary share transfer | Undisclosed | Buyer: 3 individuals Seller: Madhubani Investments Private Limited , 2 individuals |
| Dec 2006 | Funding round | ₹6.5 Cr | Investors: GVK Davix Technologies Private Limited , 3 individuals |
| Mar 2006 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: GVK Davix Technologies Private Limited , 3 individuals |
| Dec 2005 | Acquisition | ₹1.98 Cr | Buyer: GVK Davix Technologies Private Limited |
Full deal history
All 26 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Aragen Life Sciences Limited
Aragen Life Sciences Limited has 32 court cases on record: 11 filed by Aragen Life Sciences, 19 filed against it, 2 where it is another party. 10 cases are pending and 22 are disposed. Status as checked between 21 Sep 2026 and 04 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 18 | 12 | 8 |
| District courts | 14 | 7 | 2 |
Cases on record (5 of 32)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Hyderabad CCC, Telangana | Court case (CC.NI) | Filed by the company against Gifting Solutions Private Limited | Pending |
| District court, Mumbai City Civil Court, Maharashtra | Interim or miscellaneous application | Filed against the company by Kpit Global Solutions Limited | Disposed |
| High Court for State of Telangana | Company petition | Filed against the company by Aloe Hotels and Resorts Private Limited | Disposed |
| High Court for State of Telangana | Court case (ITTA) | Filed by the company against Assistant Commissioner of Income Tax | Pending |
| District court, Medchal Malkajgiri, Telangana | Civil suit | Company is another party | Pending |
Full case history
All 32 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME Payment Delays by Aragen Life Sciences Limited
Aragen Life Sciences Limited has 46 MSME Form 1 returns on record between 2010 and 2024, listing 19,298 overdue payments to 864 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 864)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Sun Tech Precision | •••• | •••• | •••• |
| Dekra India Private Limited | •••• | •••• | •••• |
| Panchami Logistics and Enterprises | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
Full MSME payment history
Every supplier, amount and due date from all 46 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Associated Brands with Aragen Life Sciences Limited
Aragen Life Sciences operates two associated brands: GVK Davix Technologies and Aragen Life Sciences. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Provider of drug preclinical and formulation development services | gvkbio.com | |
| Aragen Life Sciences is engaged in contract research and manufacturing for pharmaceuticals. | aragen.com |
Employees and EPFO Compliance at Aragen Life Sciences Limited
Aragen Life Sciences Limited has a workforce of 3,859 employees as of Apr 08, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Group Structure of Aragen Life Sciences Limited
Aragen Life Sciences has 2 subsidiary companies. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares Held |
|---|---|---|
| Intox Private Limited | U74999PN2000PTC015116 | Locked |
| Aragen Foundation | U85300DL2021NPL391515 | Locked |
Showing major subsidiaries. Total: 2.
CIN History of Aragen Life Sciences Limited
Aragen Life Sciences has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U74999TG2000PLC035826, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U74999TG2000PLC035826 | Current |
| U74999AP2000PTC035826 | Previous |
| U74999TG2000PTC035826 | Previous |
News related to Aragen Life Sciences Limited
Recent Activity on Aragen Life Sciences Limited
Aragen Life Sciences Limited has 28 board changes on record since 2004: 9 appointments and 19 cessations. The latest: Amit Varma ceased to be Additional Director on 10 Jan 2025.
74 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Aragen Life Sciences Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Aragen Life Sciences Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Aragen Life Sciences Limited
Aragen Life Sciences has 12 GST registrations: 6 active and 6 cancelled or inactive. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AABCG3208J1ZT | Telangana | Active | 01 Jul 2017 |
| 36AABCG3208J2ZS | Telangana | Active | 28 Dec 2021 |
| 07AABCG3208J1ZU | Delhi | Active | 01 Jul 2017 |
| 29AABCG3208J1ZO | Karnataka | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Aragen Life Sciences Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aragen Life Sciences Limited
Aragen Life Sciences is an active public limited company based in Hyderabad, Telangana, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 07 December 2000 (26+ years old) and is registered under CIN U74999TG2000PLC035826.
Aragen Life Sciences reported revenue of ₹1,870.29 Cr for FY 2025 (up 12% YoY).
Aragen Life Sciences has 9 current directors and KMP:
- Manmahesh Kantipudi - Managing Director
- Davinder Singh Brar - Director
- Amit Varma - Director
- Ajay Srivastava - Director
- Anita Ramachandran - Director
- Rajat Sood - Director
- Robert Richard Ruffolo - Director
- Gunapati Reddy Venkat Keshav - Director
- Sachin Anand Dharap - Cfo
Aragen Life Sciences reported a net profit of ₹180.38 Cr (net margin 9.6%) and EBITDA of ₹478.48 Cr (EBITDA margin 25.6%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Aragen Life Sciences is 10% over three years and 14% over five years. In the latest year (FY 2025) revenue rose 12%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Aragen Life Sciences is 36AABCG3208J1ZT, registered in Telangana. The company has 12 GST registrations in all, of which 6 are active and 6 are cancelled or inactive. Other active GSTINs include 36AABCG3208J2ZS (Telangana), 07AABCG3208J1ZU (Delhi), 29AABCG3208J1ZO (Karnataka).
The CIN (Corporate Identification Number) of Aragen Life Sciences is U74999TG2000PLC035826. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aragen Life Sciences has 32 court cases on record: 11 filed by the company and 19 filed against it. 10 are pending. Most are in the high courts.
Aragen Life Sciences was incorporated on 07 December 2000, making it 26+ years old. It is registered with the Registrar of Companies, Hyderabad.
Aragen Life Sciences has 26 deals on record (21 secondary share transfers, 4 funding rounds, 1 acquisition), with disclosed funding of ₹1,040.25 Cr; the latest was in August 2025.
The peers of Aragen Life Sciences by revenue are Iol Chemicals and Pharmaceuticals Limited, Tianish Laboratories Private Limited, Pfizer Healthcare India Private Limited, MSN Life Sciences Private Limited, Anthem Biosciences Limited and 5 more, all in the Pharma industry (API Manufacturers, Contract Research).
Amit Varma ceased to be Additional Director on 10 Jan 2025. Amit Varma was appointed as Director on 09 Jan 2025. Sachin Anand Dharap was appointed as CFO on 25 Jan 2023. Aragen Life Sciences has 28 board changes on record in total.